Insider · CIK 0001373603
Braden Michael Leonard
owner
Files at ASTC (ASTROTECH Corp), OM (Outset Medical, Inc.), ADVM (Adverum Biotechnologies, Inc.), ANTX (AN2 Therapeutics, Inc.). First filing Feb 28, 2025, latest Oct 5, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
8 / 5
$4.7M bought, $9.3M sold
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
ANTX: AN2 Therapeutics, Inc.
ANTXOct 9, 2026 · close 4.40
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
OM: Outset Medical, Inc.
OMOct 9, 2026 · close 4.05
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | OMbuy Outset Medical, Inc. | $870k 244,909 shares | +10% | +27% from low-76% from high | |
| 42Moderate | ADVMsell Adverum Biotechnologies, Inc. | $2.2M 524,560 shares | -21% | - | |
| 42Moderate | ADVMsell Adverum Biotechnologies, Inc. | $2.4M 574,886 shares | -19% | - | |
| 57Moderate | ASTCsell ASTROTECH Corp | $1.6M 229,576 shares | -104% | +24% from low-30% from high | |
| 24Weak | ANTXsell AN2 Therapeutics, Inc. | $218k 200,000 shares | -6% | +15% from low-31% from high | |
| 47Moderate | ANTXsell AN2 Therapeutics, Inc. | $2.9M 2,532,000 shares | -44% | +15% from low-31% from high | |
| 30Weak | ADVMbuy Adverum Biotechnologies, Inc. | $189k 37,000 shares | +35% | - | |
| 30Weak | ADVMbuy Adverum Biotechnologies, Inc. | $189k 37,000 shares | +35% | - | |
| 40Moderate | ADVMbuy Adverum Biotechnologies, Inc. | $1.0M 350,000 shares | +13% | - | |
| 23Weak | ADVMbuy Adverum Biotechnologies, Inc. | $147k 34,775 shares | +1% | - | |
| 30Weak | ADVMbuy Adverum Biotechnologies, Inc. | $189k 37,000 shares | +35% | - | |
| 31Weak | ADVMbuy Adverum Biotechnologies, Inc. | $588k 117,941 shares | +5% | - | |
| 35Weak | ADVMbuy Adverum Biotechnologies, Inc. | $1.4M 336,756 shares | +15% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | OM Outset Medical, Inc. | POpen-market purchase Common Stockindirect: Holdings of BML Investment Partners, L.P. | +228,334 | $3.53 | $806k | 2,748,035 | 7 d ago |
| Oct 2, 2026 | OM Outset Medical, Inc. | POpen-market purchase Common Stockindirect: Holdings of BML Investment Partners, L.P. | +16,575 | $3.88 | $64k | 2,764,610 | 7 d ago |
| Dec 4, 2025 | ADVM Adverum Biotechnologies, Inc. | SOpen-market sale Common Stockindirect: Holdings of BML Investment Partners, L.P. | -524,560 | $4.19 | $2.2M | 1,958,080 | Dec 5, 2025 |
| Dec 1, 2025 | ADVM Adverum Biotechnologies, Inc. | SOpen-market sale Common Stockindirect: Holdings of BML Investment Partners, L.P | -300,000 | $4.20 | $1.3M | 2,757,526 | Dec 3, 2025 |
| Dec 2, 2025 | ADVM Adverum Biotechnologies, Inc. | SOpen-market sale Common Stockindirect: Holdings of BML Investment Partners, L.P | -51,961 | $4.20 | $218k | 2,705,565 | Dec 3, 2025 |
| Dec 3, 2025 | ADVM Adverum Biotechnologies, Inc. | SOpen-market sale Common Stockindirect: Holdings of BML Investment Partners, L.P | -222,925 | $4.17 | $930k | 2,428,640 | Dec 3, 2025 |
| Oct 3, 2025 | ASTC ASTROTECH Corp | SOpen-market sale Common Stockindirect: Holdings of BML Investment Partners, L.P | -220,410 | $7.13 | $1.6M | 0 | Oct 7, 2025 |
| Oct 3, 2025 | ASTC ASTROTECH Corp | SOpen-market sale Common Stock | -9,166 | $5.83 | $53k | 0 | Oct 7, 2025 |
| May 28, 2025 | ANTX AN2 Therapeutics, Inc. | SOpen-market sale Common Stockindirect: Holding of BML Investment Partners, L.P. | -200,000 | $1.09 | $218k | 3,017,432 | Jun 16, 2025 |
| May 28, 2025 | ANTX AN2 Therapeutics, Inc. | SOpen-market sale Common Stockindirect: Holding of BML Investment Partners, L.P. | -2,000,000 | $1.16 | $2.3M | 3,749,432 | May 30, 2025 |
| May 28, 2025 | ANTX AN2 Therapeutics, Inc. | SOpen-market sale Common Stockindirect: Holding of BML Investment Partners, L.P. | -100,000 | $1.16 | $116k | 3,649,432 | May 30, 2025 |
| May 30, 2025 | ANTX AN2 Therapeutics, Inc. | SOpen-market sale Common Stockindirect: Holding of BML Investment Partners, L.P. | -425,000 | $1.01 | $429k | 3,224,432 | May 30, 2025 |
| May 30, 2025 | ANTX AN2 Therapeutics, Inc. | SOpen-market sale Common Stockindirect: Holding of BML Investment Partners, L.P. | -7,000 | $1.03 | $7,227 | 3,217,432 | May 30, 2025 |
| Mar 26, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stock | +20,407 | $5.04 | $103k | 125,207 | Apr 28, 2025 |
| Mar 26, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stock | +20,407 | $5.04 | $103k | 125,207 | Apr 28, 2025 |
| Mar 27, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stock | +16,593 | $5.19 | $86k | 141,800 | Apr 28, 2025 |
| Mar 27, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stock | +16,593 | $5.19 | $86k | 141,800 | Apr 28, 2025 |
| Apr 22, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stockindirect: Holdings of BML Investment Partners, L.P. | +300,000 | $3.00 | $900k | 3,057,526 | Apr 24, 2025 |
| Apr 23, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stock | +50,000 | $2.98 | $149k | 191,800 | Apr 24, 2025 |
| Mar 31, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stockindirect: Holdings of BML Investment Partners, L.P. | +19,566 | $4.38 | $86k | 2,742,317 | Apr 2, 2025 |
| Apr 2, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stockindirect: Holdings of BML Investment Partners, L.P | +15,209 | $4.04 | $61k | 2,757,526 | Apr 2, 2025 |
| Mar 26, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stock | +20,407 | $5.04 | $103k | 125,207 | Mar 27, 2025 |
| Mar 27, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stock | -16,593 | $5.19 | $86k | 141,800 | Mar 27, 2025 |
| Mar 18, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stockindirect: Holding of BML Investment Partners, L.P. | +18,000 | $4.60 | $83k | 2,622,820 | Mar 20, 2025 |
| Mar 18, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stockindirect: Holding of BML Investment Partners, L.P. | +44,341 | $4.73 | $210k | 2,667,161 | Mar 20, 2025 |
| Mar 19, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stockindirect: Holding of BML Investment Partners, L.P. | +25,000 | $4.94 | $123k | 2,692,161 | Mar 20, 2025 |
| Mar 20, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stovkindirect: Holding of BML Investment Partners, L.P. | +30,600 | $5.61 | $172k | 2,722,761 | Mar 20, 2025 |
| Feb 26, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stockindirect: Holding of BML Investment Partners, L.P. | +164,886 | $4.01 | $661k | 2,432,950 | Feb 28, 2025 |
| Feb 27, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stockindirect: Holding of BML Investment Partners, L.P. | +86,802 | $4.46 | $387k | 2,519,752 | Feb 28, 2025 |
| Feb 28, 2025 | ADVM Adverum Biotechnologies, Inc. | POpen-market purchase Common Stockindirect: Holding of BML Investment Partners, L.P. | +85,068 | $4.60 | $391k | 2,604,820 | Feb 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.